AI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 Diabetes

NCT07697391 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

285

Enrollment

OTHER

Sponsor class

Conditions

Obesity
Diabetes Mellitus, Type 2

Interventions

BEHAVIORAL: AI-Assisted Intensive Lifestyle Intervention
DRUG: Tirzepatide
BEHAVIORAL: Standard Lifestyle Management

Sponsor

The First Affiliated Hospital of Anhui Medical University

Collaborators

[object Object]